Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A pan-cancer analysis of SLC1A5 in human cancers

1 Jun 2023

Abstract excerpt

Background: The alanine-serine-cysteine transporter 2, ASCT2 (solute carrier family 1 member 5, SLC1A5), is a major transporter of the amino acid, glutamine. Although SLC1A5 has been reported to be associated with some types of cancer, less pan-cancer analysis, which would give a comprehensive understanding of SLC1A5 across human cancers, has been carried out. Methods: We used the TCGA and GEO databases to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Enzymes and Metabolism
Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37408893
DOI: 10.1016/j.heliyon.2023.e17598

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A pan-cancer analysis of SLC1A5 in human cancersPMID 37408893Read ↗

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerSemantic proximity Read ↗

A comprehensive analysis of SLC25A1 expression and its oncogenic role in pan-cancerSemantic proximity Read ↗

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysisSemantic proximity Read ↗

Comprehensive Analysis and Validation of Solute Carrier Family 25 (SLC25) in Pan-CancerSemantic proximity Read ↗

Comprehensive molecular and clinical characterization of SLC1A5 in human cancersSemantic proximity Read ↗

Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.Semantic proximity Read ↗

A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity.Semantic proximity Read ↗

SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironmentSemantic proximity Read ↗

Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancerSemantic proximity Read ↗

SLC1A5 Prefers to Play as an Accomplice Rather Than an Opponent in Pancreatic AdenocarcinomaSemantic proximity Read ↗

Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor typesSemantic proximity Read ↗

Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.